These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22893461)

  • 1. Modern diagnostic approaches to cholangiocarcinoma.
    Vasilieva LE; Papadhimitriou SI; Dourakis SP
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):349-59. PubMed ID: 22893461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations.
    Vasilieva LE; Papadhimitriou SI; Alexopoulou A; Pavlidis D; Kostopoulos I; Georgiakaki M; Xinopoulos D; Romanos A; Dourakis SP
    Hum Pathol; 2013 Oct; 44(10):2173-9. PubMed ID: 23845469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UroVysion Multi-Target Fluorescence in situ Hybridization Assay for the Detection of Malignant Bile Duct Brushing Specimens: A Comparison with Routine Cytology.
    Zhai J
    Acta Cytol; 2018; 62(4):295-301. PubMed ID: 29734171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fluorescence in situ hybridization in diagnosing cholangiocarcinoma in indeterminate biliary strictures.
    Liew ZH; Loh TJ; Lim TKH; Lim TH; Khor CJL; Mesenas SJ; Kong CSC; Ong WC; Tan DMY
    J Gastroenterol Hepatol; 2018 Jan; 33(1):315-319. PubMed ID: 28543841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-tissue sampling during endoscopic retrograde cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma.
    Lee SJ; Lee YS; Lee MG; Lee SH; Shin E; Hwang JH
    Gut Liver; 2014 Nov; 8(6):669-73. PubMed ID: 25368755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
    Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
    Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Factors Affecting the Sensitivity of Bile Duct Brush Cytology.
    Kobayashi M; Ryozawa S; Araki R; Nagata K; Tanisaka Y; Fujita A; Kobatake T
    Intern Med; 2019 Feb; 58(3):329-335. PubMed ID: 30146607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
    Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
    Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Njei B; McCarty TR; Varadarajulu S; Navaneethan U
    Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangiocarcinoma: principles and current trends.
    Zografos GN; Farfaras A; Zagouri F; Chrysikos D; Karaliotas K
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):10-20. PubMed ID: 21269929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
    Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
    Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma.
    Weber A; von Weyhern C; Fend F; Schneider J; Neu B; Meining A; Weidenbach H; Schmid RM; Prinz C
    World J Gastroenterol; 2008 Feb; 14(7):1097-101. PubMed ID: 18286693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
    Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
    Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
    Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
    Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangioscopy Biopsies Improve Detection of Cholangiocarcinoma When Combined with Cytology and FISH, but Not in Patients with PSC.
    Kaura K; Sawas T; Bazerbachi F; Storm AC; Martin JA; Gores GJ; Abu Dayyeh BK; Topazian MD; Levy MJ; Petersen BT; Chandrasekhara V
    Dig Dis Sci; 2020 May; 65(5):1471-1478. PubMed ID: 31571103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
    Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
    Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures.
    Levy MJ; Baron TH; Clayton AC; Enders FB; Gostout CJ; Halling KC; Kipp BR; Petersen BT; Roberts LR; Rumalla A; Sebo TJ; Topazian MD; Wiersema MJ; Gores GJ
    Am J Gastroenterol; 2008 May; 103(5):1263-73. PubMed ID: 18477350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraprocedural tissue diagnosis during ERCP employing a new cytology preparation of forceps biopsy (Smash protocol).
    Wright ER; Bakis G; Srinivasan R; Raju R; Vittal H; Sanders MK; Bernadino K; Stefan A; Blaszyk H; Howell DA
    Am J Gastroenterol; 2011 Feb; 106(2):294-9. PubMed ID: 21102569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics.
    Voigtländer T; Lankisch TO
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):267-75. PubMed ID: 25966427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.